Scienture Holdings, Inc.SCNXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Revenue
$18.7K
Gross Profit
N/A
Operating Profit
$-1.5M
Net Profit
$-1.8M
Gross Margin
N/A
Operating Margin
-7998.8%
Net Margin
-9807.5%
YoY Growth
-94.9%
EPS
$-1.30
Scienture Holdings, Inc. Q2 FY2024 Financial Summary
Scienture Holdings, Inc. reported revenue of $18.7K (down 94.9% YoY) for Q2 FY2024, with a net profit of $-1.8M (up 7.1% YoY) (-9807.5% margin).
Key Financial Metrics
| Total Revenue | $18.7K |
|---|---|
| Net Profit | $-1.8M |
| Gross Margin | N/A |
| Operating Margin | -7998.8% |
| Report Period | Q2 FY2024 |
Scienture Holdings, Inc. Annual Revenue by Year
Scienture Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $431.6K).
| Year | Annual Revenue |
|---|---|
| 2025 | $431.6K |
| 2023 | $1.4M |
| 2022 | $10.3M |
Scienture Holdings, Inc. Quarterly Revenue & Net Profit History
Scienture Holdings, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $-168.7K | — | $-28.1M | 16668.9% |
| Q3 FY2025 | $590.0K | +809.7% | $-3.6M | -611.4% |
| Q2 FY2025 | $0 | — | $-6.7M | N/A |
| Q1 FY2025 | $10.3K | — | $-3.1M | -29869.3% |
| Q3 FY2024 | $64.9K | -83.5% | $-3.2M | -4908.3% |
| Q2 FY2024 | $18.7K | -94.9% | $-1.8M | -9807.5% |
| Q4 FY2023 | $111.7K | -93.3% | N/A | N/A |
| Q3 FY2023 | $392.3K | -80.9% | $-3.5M | -898.6% |
Income Statement
| Q3 2023 | Q4 2023 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $392286 | $111702 | $18699 | $64861 | $10258 | $0 | $590050 | $-168699 |
| YoY Growth | -80.9% | -93.3% | -94.9% | -83.5% | N/A | N/A | 809.7% | N/A |
Balance Sheet
| Q3 2023 | Q4 2023 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $21.7M | $12.5M | $14.8M | $94.3M | $106.4M | $104.3M | $104.8M | $84.2M |
| Liabilities | $10.1M | $12.0M | $3.1M | $9.1M | $25.2M | $26.4M | $22.2M | $14.1M |
| Equity | $11.6M | $542353 | $11.8M | $85.1M | $81.2M | $77.9M | $82.7M | $70.1M |
Cash Flow
| Q3 2023 | Q4 2023 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-603112 | $-2.2M | $4.2M | $-5.4M | $-3.0M | $-2.0M | $-3.2M | $-5.2M |